TMO
Thermo Fisher Scientific Inc
652.00$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.8% | 34.2% | 12.1% | 18.6% | 20.4% | 28.9% | 7.0% | 12.9% | 20.1% | 28.3% | 10.8% | 17.7% | 19.5% | |
| 8.1% | 7.7% | 8.1% | 7.5% | 7.0% | 6.5% | 6.8% | 6.3% | 6.0% | 6.0% | 6.7% | 6.8% | 6.3% | |
| -1.4% | 0.6% | 0.7% | 0.8% | 0.6% | 0.7% | 0.7% | 0.7% | 0.6% | 0.7% | 0.8% | 0.7% | 0.7% | |
| -1.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.1% | 15.8% | -7.6% | -2.0% | 0.3% | 5.2% | -13.7% | -6.7% | 19.3% | 4.0% | -10.1% | 9.3% | 5.7% | |
| 3.1% | 3.7% | 3.4% | 2.9% | 2.6% | 4.2% | 3.5% | 2.7% | 3.6% | 3.8% | 3.4% | 3.8% | 3.7% | |
| -45.1% | -3.5% | -19.6% | -2.4% | -33.8% | 0.2% | -5.1% | -2.7% | -37.1% | 7.3% | -81.4% | 1.4% | -26.0% | |
| 1.3% | 1.2% | 1.3% | 1.4% | 1.4% | 1.3% | 1.4% | 1.5% | 1.5% | 1.3% | 1.5% | 1.5% | 1.4% | |
| -28.4% | 0.0% | -29.0% | 0.0% | -28.3% | -8.8% | -19.3% | -18.4% | 18.0% | -24.6% | -27.3% | -8.3% | -10.8% | |
| 18.6% | – | – | – | -10.4% | -21.9% | 19.3% | -7.3% | 4.5% | 29.8% | 38.3% | -3.2% | 17.2% | |
| 17.5% | -13.1% | -17.6% | -1.1% | -11.2% | -32.2% | -1.0% | -9.1% | -5.7% | 28.9% | 9.9% | -21.4% | 3.1% | |
| 28.5% | 17.7% | -24.9% | 15.0% | -22.9% | -5.5% | 1.3% | 4.0% | -23.3% | 64.4% | -60.0% | -1.5% | -3.3% | |
| 19.7% | 30.5% | 8.7% | 15.7% | 17.9% | 24.7% | 3.5% | 10.2% | 16.5% | 24.5% | 7.4% | 14.0% | 15.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.